Rawitscher|J Mayer - JoVE Visualize

Showing results (281-290 of 1,779) with videos related to

Pageof 178

Sort By:

Zentralblatt Fur Hygiene Und Umweltmedizin = International Journal of Hygiene and Environmental Medicine|October 28, 1998

[Failure conditions of glass filament yarns: a contribution to the valuation of carcinogenic potentials of fiber fragments]M Oser, C Ramseyer, J Mayer, et al.

Biochemical and Biophysical Research Communications|September 23, 2009

MicroRNA isolation and stability in stored RNA samplesM Mraz, K Malinova, J Mayer, et al.

Vnitrni Lekarstvi|March 1, 1994

[Use of bronchoalveolar lavage in the diagnosis of pulmonary complications in immunocompromised patients]J Mayer, J Skricková, J Vorlícek, et al.

Regulatory Toxicology and Pharmacology : RTP|November 21, 2007

Structure-activity relationship analysis tools: validation and applicability in predicting carcinogensJ Mayer, M A Cheeseman, M L Twaroski

European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|January 1, 1991

Preinvasive stages of adenocarcinoma of the nose after exposure to wood dustO Kleinsasser, H G Schroeder, J Mayer-Brix

Casopis Lekaru Ceskych|June 27, 2008

[Therapy of chronic myeloid leukemia. Uncommon view of the modern approaches]J Mayer, D Zácková, H Klamová, et al.

Wiener Klinische Wochenschrift|March 15, 2003

[Treatment of renal anemia with darbepoetin alfa: results of an Austrian multicenter study]Walter H Hörl, Herwig Holzer, Gert J Mayer, et al.

Neoplasma|February 3, 2012

Kinetics of bilirubin and liver enzymes is useful for predicting of liver graft-versus-host diseaseM Krejci, J Kamelander, Z Pospisil, et al.

Journal of Muscle Research and Cell Motility|December 29, 2000

The T-tubular network and its triads in the sole plate sarcoplasm of the motor end-plate of mammalsW Dauber, T Voigt, X Härtel, et al.

Vnitrni Lekarstvi|November 6, 2001

[Non-cytostatic treatment of malignancies. Anti-CD20 monoclonal antibody (Rituximab, Mabthera) in the treatment of non-Hodgkin's lymphoma]J Mayer, M Navrátil, J Vásová, et al.

Pageof 178

Showing results (281-290 of 1,779) with videos related to

Sort By:

Pageof 178

Zentralblatt Fur Hygiene Und Umweltmedizin = International Journal of Hygiene and Environmental Medicine|October 28, 1998

[Failure conditions of glass filament yarns: a contribution to the valuation of carcinogenic potentials of fiber fragments]M Oser, C Ramseyer, J Mayer, et al.

Biochemical and Biophysical Research Communications|September 23, 2009

MicroRNA isolation and stability in stored RNA samplesM Mraz, K Malinova, J Mayer, et al.

Vnitrni Lekarstvi|March 1, 1994

[Use of bronchoalveolar lavage in the diagnosis of pulmonary complications in immunocompromised patients]J Mayer, J Skricková, J Vorlícek, et al.

Regulatory Toxicology and Pharmacology : RTP|November 21, 2007

Structure-activity relationship analysis tools: validation and applicability in predicting carcinogensJ Mayer, M A Cheeseman, M L Twaroski

Preinvasive stages of adenocarcinoma of the nose after exposure to wood dustO Kleinsasser, H G Schroeder, J Mayer-Brix

Casopis Lekaru Ceskych|June 27, 2008

[Therapy of chronic myeloid leukemia. Uncommon view of the modern approaches]J Mayer, D Zácková, H Klamová, et al.

Wiener Klinische Wochenschrift|March 15, 2003

[Treatment of renal anemia with darbepoetin alfa: results of an Austrian multicenter study]Walter H Hörl, Herwig Holzer, Gert J Mayer, et al.

Neoplasma|February 3, 2012

Kinetics of bilirubin and liver enzymes is useful for predicting of liver graft-versus-host diseaseM Krejci, J Kamelander, Z Pospisil, et al.

Journal of Muscle Research and Cell Motility|December 29, 2000

The T-tubular network and its triads in the sole plate sarcoplasm of the motor end-plate of mammalsW Dauber, T Voigt, X Härtel, et al.

Vnitrni Lekarstvi|November 6, 2001

[Non-cytostatic treatment of malignancies. Anti-CD20 monoclonal antibody (Rituximab, Mabthera) in the treatment of non-Hodgkin's lymphoma]J Mayer, M Navrátil, J Vásová, et al.

Pageof 178